The global market for tendonitis treatment market is projected to have a considerable CAGR of around 2.6% during the forecast period. Tendonitis is an acute chronic condition when tendons get irritated and inflamed. This inflammation from tendonitis can cause various issues such as mobility loss and pain, decreased muscle strength from where the tendon arises. The market is anticipated to grow due to several factors including increased prevalence of tendonitis as a result of the aging population, sports, and occupational work injuries, and sudden injuries caused by physical activity and trauma. Furthermore, when children and teenagers use more electronic devices, they become more prone to problems with their hands, arms, and wrists, increasing their chances of developing tendonitis. Additionally, as various treatment options such as physical therapy, over-the-counter pain medications, and various surgical treatments have become more widely available, the number of people seeking treatment has increased, thereby aiding the market growth. However, treatment-related side effects, the recurrent nature of sudden injuries, and prolonged inactivity, which causes stiff joints, are some of the factors restraining market growth.
Segmental Outlook
The global tendonitis treatment market is segmented based on the condition and treatment. Based on the condition, the market is segmented into Achilles tendonitis, supraspinatus tendonitis, tennis elbow, golfer’s elbow, and pitcher’s elbow. Based on the treatment the market is further categorized as surgical treatment, physical therapy, shockwave therapy, and others.
Global Tendonitis Treatment Market Share by condition, 2021 (%)
The Tennis Elbow Segment Is Considered The Dominating Segment in the Global Tendonitis Treatment Market.
Among conditions, the tennis elbow segment is estimated as dominating segment during the forecast period owing to factors such as the availability of cost-effective treatment options, and new product launches. According to a study published in March 2019 titled new interventional radiology treatment for tennis elbow" reduces pain and inflammation without any surgery. When 52 patients with tennis elbow who had not found relief from other treatments were treated with Transcatheter Arterial Embolization (TAE) from 2013 to 2017 and followed up for four years after the treatment, a statistically significant rate of pain relief among the patients was observed. Moreover, tennis elbow is more common in people over the age of 40, according to an article titled Tennis Elbow published in July 2021. According to the National Safety Council (NSC) facts and figures for injury in the United States 2020 reports, bicycling accounted for about 426,000 injuries, the most of any category of sports and recreation. Therefore, the increasing number of sports injuries and the prevalence of the disease in an elder population is boosting the market growth for the tennis elbow segment in the forecast period.
Regional Outlook
Geographically, the global Tendonitis Treatment market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific (India, China, Japan, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Asia-Pacific is projected to have a significant CAGR in the tendonitis treatment market owing to the growing number of tendonitis surgeries performed in the region and rising disposable income. Moreover, increasing products in the pipeline for tendonitis treatment, particularly in China and Japan, coupled with an increasing number of sports-related injuries will also be driving the growth of the market.
Global Tendonitis Treatment Market Growth, by region 2022-2028
North America to Hold a Considerable Share in the Global Tendonitis Treatment Market
Geographically, North America is projected to hold a significant share in the global Tendonitis Treatment market. The factors that are contributing to the growth of the market include awareness among common people about the disease being more than other regions and higher expenditure on advancements of healthcare. Owing to the presence of well-established healthcare facilities, the rise in geriatric population in the region, along with other factors, like the rising number of orthopedic procedures, North America is likely to dominate the market growth. According to annual data published by the United States Bureau of Labor Statistics for Employer-Reported Workplace Injuries and Illnesses in 2020, there were 266,530 sprains, strains, and tears leading to tendonitis in the US with 1,380 tendonitis patients. Another epidemiological research on tennis elbow in United States statistics published in March 2021 found that roughly, 1 in 10 patients suffering from tennis elbow disease having persistent symptoms for more than 6 months required surgery, but around 8.5% of patients complained about the recurrence of the disease within 2 years. Due to recurrence of the disease within two years after diagnosis, the proportion of surgically treated cases tripled to 3.2%. Tendonitis is becoming more prevalent in the United States and other parts of North America, which is driving up demand for tendonitis treatment in the region.
Market Players Outlook
The key players in the tendonitis treatment market contribute significantly by providing different types of products and increasing their geographical presence across the globe. DJO Global Inc., Zimmer Biomet, 3M Co, and AKSIGEN among others. These market players adopt various strategies such as product launches, partnerships, collaborations, mergers, and acquisitions to sustain a strong position in the market. In December 2021, Singapore engineering firm Delson, in collaboration with 3D printing specialists from Nanyang Technological University (NTU), Singapore developed the X-Brace which is almost 30% lighter than traditional exoskeleton knee braces. Using 3D printing techniques also known as additive manufacturing - the team has managed to reduce the weight of a traditional exoskeleton knee brace, typically built using metal, by 30%.
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Tendonitis Treatment Industry
• Recovery Scenario of Global Tendonitis Treatment Industry
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Tendonitis Treatment Market by Condition
5.1.1. Achilles Tendonitis
5.1.2. Supraspinatus Tendonitis
5.1.3. Tennis Elbow
5.1.4. Golfer’s Elbow
5.1.5. Pitcher’s Elbow
5.2. Global Tendonitis Treatment Market by Treatment
5.2.1. Surgical Treatment
5.2.2. Physical therapy
5.2.3. Shockwave Therapy
5.2.4. Others (Hot and Cold Therapy)
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. ASEAN
6.3.5. South Korea
6.3.6. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. 3M Co
7.2. Abbott
7.3. Aksigen Hospital Care
7.4. Almatica Pharma, Inc.
7.5. AstraZeneca
7.6. Bayer AG
7.7. Boehringer Ingelheim Pharmaceuticals, Inc.
7.8. DJO Global, Inc.
7.9. GlaxoSmithKline PLC
7.10. Integra Life Sciences Corp
7.11. Merck and Co., Inc.
7.12. Össur hf.
7.13. Pfizer
7.14. Replicel Life Sciences
7.15. Smith+Nephew
7.16. Stryker Corp
7.17. Teikoku Pharma USA, Inc
7.18. Teva Pharmaceuticals Industries
7.19. Tynor Orthotics Private Limited
7.20. Zimmer Biomet
1. GLOBAL TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
2. GLOBAL TENDONITIS TREATMENT FOR ACHILLES TENDONITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL TENDONITIS TREATMENT FOR SUPRASPINATUS TENDONITIS MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
4. GLOBAL TENDONITIS TREATMENT FOR TENNIS ELBOW MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
5. GLOBAL TENDONITIS TREATMENT FOR GOLFER’S ELBOW MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
6. GLOBAL TENDONITIS TREATMENT FOR PITCHER’S ELBOW MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
7. GLOBAL TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
8. GLOBAL SURGICAL TREATMENT IN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL PHYSICAL THERAPY IN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL SHOCKWAVE THERAPY IN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL TENDONITIS TREATMENT MARKET FOR OTHER TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14. NORTH AMERICAN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
15. NORTH AMERICAN MAGNESIUM ALLOYSMARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
16. EUROPEAN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. EUROPEAN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
18. EUROPEAN TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
21. ASIA-PACIFIC TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
22. REST OF THE WORLD TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY CONDITION, 2021-2028 ($ MILLION)
23. REST OF THE WORLD TENDONITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL TENDONITIS TREATMENT MARKETMARKET, 2021-2028 (% MILLION)
2. IMPACT OF COVID-19 ON GLOBAL TENDONITIS TREATMENT MARKETMARKET BY SEGMENT, 2021-2028 (% MILLION)
3. RECOVERY OF TENDONITIS TREATMENT MARKETMARKET, 2021-2028 (%)
4. GLOBAL TENDONITIS TREATMENT MARKET SHARE BY CONDITION, 2021 VS 2028 (%)
5. GLOBAL TENDONITIS TREATMENT MARKET SHARE BY TREATMENT, 2021 VS 2028 (%)
6. GLOBAL TENDONITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL TENDONITIS TREATMENT FOR ACHILLES TENDONITIS MARKET SIZE, 2021-2028 ($ MILLION)
8. GLOBAL TENDONITIS TREATMENT FOR SUPRASPINATUS TENDONITIS MARKET SIZE, 2021-2028 ($ MILLION)
9. GLOBAL TENDONITIS TREATMENT FOR TENNIS ELBOW MARKET SIZE, 2021-2028 ($ MILLION)
10. GLOBAL TENDONITIS TREATMENT FOR GOLFER’S ELBOW MARKET SIZE, 2021-2028 ($ MILLION)
11. GLOBAL TENDONITIS TREATMENT FOR PITCHER’S ELBOW MARKET SIZE, 2021-2028 ($ MILLION)
12. GLOBAL SURGICAL TREATMENT IN TENDONITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL PHYSICAL THERAPY IN TENDONITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL SHOCKWAVE THERAPY IN TENDONITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL TENDONITIS TREATMENT FOR OTHER TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. US TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
17. CANADA TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
18. UK TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
19. FRANCE TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
20. GERMANY TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
21. ITALY TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
22. SPAIN TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
23. ROE TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
24. INDIA TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
25. CHINA TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
26. JAPAN TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
27. ASEAN TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
28. SOUTH KOREA TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF ASIA-PACIFIC TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
30. REST OF THE WORLD TENDONITIS TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)